Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.69 USD | +12.64% |
|
+33.96% | +283.15% |
Jun. 10 | Lipocine Inc. Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late-Breaking Session at EASL Congress 2024 | CI |
May. 09 | Earnings Flash (LPCN) LIPOCINE Reports Q1 Revenue $7.6M | MT |
Business Summary
Number of employees: 17
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Oral Delivery Solutions
100.0
%
| 1 | 100.0 % | -3 | 100.0 % | -670.16% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | -3 | 100.0 % | -670.16% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mahesh Patel
CEO | Chief Executive Officer | 67 | 96-12-31 |
Anthony DelConte
CTO | Chief Tech/Sci/R&D Officer | 66 | - |
Krista Fogarty
AUD | Comptroller/Controller/Auditor | 56 | 18-09-30 |
Corporate Officer/Principal | 55 | 14-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Ono
BRD | Director/Board Member | 71 | 14-01-05 |
Mahesh Patel
CEO | Chief Executive Officer | 67 | 96-12-31 |
John Higuchi
BRD | Director/Board Member | 56 | 12-12-31 |
Jeffrey Fink
BRD | Director/Board Member | 66 | 14-01-05 |
Jill Jene
BRD | Director/Board Member | 51 | 22-04-10 |
Chairman | 52 | 22-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,348,276 | 5,192,543 ( 97.09 %) | 336 ( 0.006282 %) | 97.09 % |
Company contact information
![address Lipocine Inc.(LPCN)](https://cdn.zonebourse.com/static/address/16085349.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+283.15% | 50.75M | |
+16.42% | 124B | |
+19.02% | 112B | |
+3.52% | 22.94B | |
-11.63% | 17.02B | |
-16.50% | 16.88B | |
-39.57% | 16.87B | |
+2.68% | 13.63B | |
+21.16% | 11.61B | |
+108.78% | 10.31B |
- Stock Market
- Equities
- LPCN Stock
- Company Lipocine Inc.